Showing results (2311-2320 of 4,124) with videos related to
Sort By:
Pageof 413
Human Gene Therapy|September 15, 2009
The current state of head and neck cancer gene therapySufi Mary Thomas, Jennifer Rubin GrandisHuman Gene Therapy|August 15, 2009
T cell receptor (TCR) gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naive and memory T cells without prior stimulation of endogenous TCRPaola Circosta, Luisa Granziero, Antonia Follenzi, et al.Human Gene Therapy|August 13, 2009
Therapeutic vaccination with an interleukin-2-interferon-gamma-secreting allogeneic tumor vaccine in patients with progressive castration-resistant prostate cancer: a phase I/II trialThomas H Brill, Hubert R Kübler, Heike Pohla, et al.Human Gene Therapy|August 13, 2009
Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeysXiaomin Su, Adrian P Kells, Eric J Huang, et al.Human Gene Therapy|July 4, 2009
Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic miceShanthi Ganesh, Melissa Gonzalez-Edick, Douglas Gibbons, et al.Human Gene Therapy|March 11, 2011
Use of DAF-displaying adenovirus vectors reduces induction of transgene- and vector-specific adaptive immune responses in miceSergey S Seregin, Yasser A Aldhamen, Daniel M Appledorn, et al.Human Gene Therapy|March 9, 2011
Reproducible high yields of recombinant adeno-associated virus produced using invertebrate cells in 0.02- to 200-liter culturesSylvain Cecchini, Tamas Virag, Robert M KotinHuman Gene Therapy|August 10, 1997
Induction of a cAMP-stimulated chloride secretion in regenerating poorly differentiated airway epithelial cells by adenovirus-mediated CFTR gene transferF Dupuit, T Chinet, J M Zahm, et al.Human Gene Therapy|February 4, 1998
Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cellsH Hanenberg, K Hashino, H Konishi, et al.Human Gene Therapy|February 4, 1998
Enhanced immunogenicity of B cell lymphoma genetically engineered to express both B7-1 and interleukin-12E Pizzoferrato, N R Chu, T S Hawley, et al.Pageof 413